ATLAS
Live / Applied — Statement of use — final refusal mailed (as of 10 Feb 2026)
What this means for you
Not registered yet, but its 26 Aug 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97567578
- Mark type
- Stylized text
- Filed
- 26 Aug 2022
- Published for opposition
- 18 Jul 2023
- Attorney of record
- Steven Rinehart
Goods and services
- Class 005 — Pharmaceuticals: Human allograft bone and tissue; Human allograft tissue
Owner
- KolosisBio, LLC, Salt Lake City, UT, US
- KolosisBio, LLC, Salt Lake City, UT, US
Prosecution history
- 10 Feb 2026 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 10 Feb 2026 — FINAL REFUSAL E-MAILED
- 10 Feb 2026 — SU - FINAL REFUSAL - WRITTEN
- 22 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 22 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jan 2026 — ASSIGNED TO LIE
- 14 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 18 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 18 Oct 2025 — NON-FINAL ACTION E-MAILED
- 18 Oct 2025 — SU - NON-FINAL ACTION - WRITTEN
- 03 Sept 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Aug 2025 — USE AMENDMENT FILED
- 19 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 21 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Feb 2025 — SOU EXTENSION 3 GRANTED